Panuveitis following Vaccination for COVID-19

Lucy I. Mudiea Sue Anschutz-Rodgers UCHealth Eye Centers, Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA

, MD MPH,

Jon D. Zickb Colorado Retina Associates, Englewood, Colorado, USA

, OSC,

Mark S. Daceyb Colorado Retina Associates, Englewood, Colorado, USA

, MD &

Alan G. Palestinea Sue Anschutz-Rodgers UCHealth Eye Centers, Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USACorrespondence[email protected]

, MD

References

François J, Collery AS, Hayek G, et al. Coronavirus disease 2019–associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2021;139(2):247–249. Published online December 17, 2020. doi:https://doi.org/10.1001/jamaophthalmol.2020.5695.
PubMed Web of Science ®Google Scholar
Benito-Pascual B, Gegúndez JA, Díaz-Valle D, et al. Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925.doi:https://doi.org/10.1080/09273948.2020.1792512.
PubMed Web of Science ®Google Scholar
Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye. 1–2. Published online July 3, 2020. doi:https://doi.org/10.1038/s41433-020-1069-8 .
Google Scholar
Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review. Indian J Ophthalmol. 2020;68(9):1799–1807. doi:https://doi.org/10.4103/ijo.IJO_816_20.
PubMed Web of Science ®Google Scholar
Vounotrypidis P. COVID-19: an archetype innate immunity reaction and modes of treatment. Mediterr J Rheumatol. 2020;31(Suppl 2):275–283. doi:https://doi.org/10.31138/mjr.31.3.275.
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Panuveitis following Vaccination for COVID-19

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Panuveitis following Vaccination for COVID-19

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date